查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1396951

流式細胞儀市場：按組件、按技術、按應用、按最終用戶：2023-2032 年全球機會分析和產業預測

Flow Cytometry Market By Component, By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 360 Pages | 商品交期: 2-3個工作天內

價格

2022年流式細胞儀市場價值為621642萬美元，預計到2032年將達到1657798萬美元，2023年至2032年的年複合成長率為10.3%。

流式細胞儀是一種強大的技術，用於分析和量化異質混合物中單一細胞和顆粒的特性。流式細胞儀的原理是使細胞通過狹窄的液體管並沿直線傳遞雷射光束。當細胞穿過雷射光束時，它們會散射並螢光，由檢測器收集。流式細胞儀可以測量每個細胞的各種參數，例如細胞大小、形狀、粒度以及用螢光標記標記的特定蛋白質和分子的存在。這些資訊經過處理後可創建細胞群的多維概況，為細胞組成、健康和功能提供有價值的見解。推動流式細胞儀市場成長的主要因素包括流式細胞儀技術的進步、流式細胞儀技術在各種研究和診斷應用中的廣泛採用。

流式細胞儀的技術進步已成為流式細胞儀市場的主要促進因素，徹底改變了這種強大分析技術的功能和應用。流式細胞儀可以快速分析異質樣本中的數千個單一細胞和顆粒，並從近年來持續的技術創新中受益匪淺。螢光成像和基於影像的分析的技術進步徹底改變了研究人員和臨床醫生分析液體樣本中細胞和顆粒的方式。

螢光成像是一種可視化帶有螢光標記的細胞和顆粒的技術，大大提高了流式細胞儀的準確性和靈敏度。該技術允許同時測量單一細胞內的多個參數，提供對細胞結構和功能的詳細了解。例如，2022年1月，全球醫療科技公司Becton Dickinson & Company宣布與歐洲分子生物學研究所合作研究。這項研究在流式細胞儀中添加了螢光成像和基於圖像的分析，不僅根據生物標記的類型和數量，而且根據每個細胞的視覺細節，非常快速地對單個細胞進行分類，BD的新技術受到了高度評價。這項新技術有可能徹底改變免疫學、細胞生物學和基因組學研究，從而促進新的細胞治療方法的發現。因此，流式細胞儀技術的進步預計將推動市場成長。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 技術進步
      • 流式細胞儀技術在疾病診斷的採用率較高
      • 流式細胞儀技術在藥物研發發現和藥物開發的採用迅速增加。
    • 抑制因素
      • 設備高成本
    • 機會
      • 將人工智慧整合到流式細胞儀中

第4章流式細胞儀市場：依組成部分

  • 概述
  • 裝置
    • 設備流式細胞儀市場：按類型
      • 平台流式細胞儀市場：按類型
      • 可更換組件流式細胞儀市場：按類型
  • 試劑/消耗品
    • 試劑和消耗品流式細胞儀市場：按類型
  • 軟體
  • 服務

第5章流式細胞儀市場：依技術分類

  • 概述
  • 基於細胞的流式細胞儀
  • 基於微珠的流式細胞儀

第6章流式細胞儀市場：依應用

  • 概述
  • 學術/臨床用途
    • 學術/臨床流式細胞儀市場：按類型
  • 診斷用途
    • 診斷流式細胞儀市場：按類型

第7章流式細胞儀市場：依最終用戶分類

  • 概述
  • 醫院
  • 醫學院/臨床實驗室
  • 商業組織
  • 學術機構
  • 其他

第8章流式細胞儀市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第9章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第10章 公司簡介

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Miltenyi Biotec GmbH.
  • Sartorius AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Cytek Biosciences
Product Code: A00023

The Flow Cytometry Market was valued at $6,216.42 million in 2022 and is estimated to reach $16,577.98 million by 2032, exhibiting a CAGR of 10.3% from 2023 to 2032. Flow cytometry is a powerful technique used to analyze and quantify the characteristics of individual cells or particles in a heterogeneous mixture. It operates on the principle of passing cells through a narrow, focused stream of fluid, allowing them to pass single file through a laser beam. As cells pass through the laser beam, they scatter and emit fluorescent light, which is collected by detectors. Flow cytometers can measure various parameters of each cell, including size, shape, granularity, and the presence of specific proteins or molecules tagged with fluorescent markers. This information is then processed to create a multi-dimensional profile of the cell population, providing valuable insights into cell composition, health, and function. Major factors that drive growth of the flow cytometry market include technological advancements in the flow cytometry and high adoption of flow cytometry techniques in various research and diagnostic applications.

Technological advancements in flow cytometry have emerged as a major driver in the flow cytometry market, revolutionizing the capabilities and applications of this powerful analytical technique. Flow cytometry, which allows for the rapid analysis of thousands of individual cells or particles in a heterogeneous sample, has benefited greatly from ongoing innovations in recent years. Technological advancements in fluorescence imaging and image-based analysis have revolutionized the way researchers and clinicians analyze cells and particles in fluid samples.

Fluorescence imaging, a technique that allows the visualization of cells and particles tagged with fluorescent markers, has greatly enhanced the precision and sensitivity of flow cytometry. This technology enables the simultaneous measurement of multiple parameters within individual cells, providing detailed insights into cell structure and function. For instance, in January 2022, Becton, Dickinson and Company, a global medical technology company, announced that a study was conducted in collaboration with the European Molecular Biology Laboratory. The study evaluated new BD innovation in flow cytometry that adds fluorescence imaging and image-based analysis to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present. The new technology has the potential to transform immunology, cell biology and genomics research and enable new cell-based therapeutic discovery. Thus, the technological advancement in the flow cytometry technology is expected to drive the growth of the market.

In addition, the high adoption of flow cytometry techniques has emerged as a major driving force in the growth of the flow cytometry market, owing to its widespread utilization in diverse research and diagnostic applications. Flow cytometry, a powerful analytical tool, has gained immense popularity in the scientific community due to its ability to simultaneously analyze multiple properties of individual cells or particles at a rapid pace. In research, it has become indispensable for studying cell biology, immunology, and cancer research, allowing scientists to analyze cell populations, sort specific cell types, and assess various cellular characteristics such as size, shape, and molecular markers. Flow cytometry has also revolutionized the field of clinical diagnostics. In the realm of clinical medicine, it plays a pivotal role in the diagnosis and monitoring of various diseases, including hematological malignancies, immunodeficiency disorders, and HIV. The ability to analyze and quantify specific biomarkers on individual cells has made flow cytometry an invaluable tool for clinical laboratories. For instance, according to a 2022 report by the National Library of Medicine, flow cytometry analysis plays a critical role in the diagnosis of leukemias and other hematolymphoid malignancies. Flow cytometry can quickly identify the abnormal cell population, characterize its phenotype, give lineage classification, make the diagnosis, or narrow down the differential list. Thus, the high adoption of flow cytometry technique in various research and diagnostic applications is expected to drive the growth of the market.

However, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Moreover, preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.

The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software, and services. The instrument segment is further divided into platforms and replaceable components. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others.

On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. As per application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others.

The diagnostic applications segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global flow cytometry market are Agilent Technologies, Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A. (Luminex Corporation), Miltenyi Biotec, Inc., Sartorius AG, Sysmex Corporation, and Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow cytometry market analysis from 2022 to 2032 to identify the prevailing flow cytometry market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the flow cytometry market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global flow cytometry market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Component

  • Instruments
    • Type
    • Platform

Type

    • Replaceable component

Type

  • Reagents and consumables
    • Type
    • Antibodies
    • Dyes
    • Beads
    • Others
  • Software
  • Services

By Technology

  • Cell based flow cytometry
  • Bead based flow cytometry

By Application

  • Academic and clinical applications
    • Type
    • Cell Cycle Analysis and Cell Proliferation
    • Apoptosis
    • Cell Sorting
    • Transfect Ion and Cell Viability
    • Others
  • Diagnostic applications
    • Type
    • Organ Transplantation
    • Hematological Malignancies
    • HIV
    • Solid Tumors and Cancer
    • Others

By End User

  • Hospitals
  • Medical schools and clinical testing labs
  • Commercial organizations
  • Academic institutions
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Bio-Rad Laboratories, Inc.
    • Miltenyi Biotec GmbH.
    • Sartorius AG
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific Inc.
    • Sysmex Corporation
    • Danaher Corporation
    • Cytek Biosciences
    • BioMerieux SA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Technological advancements
      • 3.4.1.2. High adoption of flow cytometry technique in disease diagnosis
      • 3.4.1.3. Surge in adoption of flow cytometry technique in drug discovery and development.
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of instrument
    • 3.4.3. Opportunities
      • 3.4.3.1. Integration of AI in flow cytometry

CHAPTER 4: FLOW CYTOMETRY MARKET, BY COMPONENT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Instruments
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Instruments Flow Cytometry Market by Type
      • 4.2.4.1. Platform Flow Cytometry Market by Type
      • 4.2.4.2. Replaceable component Flow Cytometry Market by Type
  • 4.3. Reagents and consumables
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Reagents and consumables Flow Cytometry Market by Type
  • 4.4. Software
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Services
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: FLOW CYTOMETRY MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cell based flow cytometry
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Bead based flow cytometry
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: FLOW CYTOMETRY MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Academic and clinical applications
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
    • 6.2.4. Academic and clinical applications Flow Cytometry Market by Type
  • 6.3. Diagnostic applications
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
    • 6.3.4. Diagnostic applications Flow Cytometry Market by Type

CHAPTER 7: FLOW CYTOMETRY MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospitals
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Medical schools and clinical testing labs
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Commercial organizations
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Academic institutions
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country
  • 7.6. Others
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by region
    • 7.6.3. Market share analysis by country

CHAPTER 8: FLOW CYTOMETRY MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Component
    • 8.2.3. Market size and forecast, by Technology
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Component
      • 8.2.6.1.2. Market size and forecast, by Technology
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Component
      • 8.2.6.2.2. Market size and forecast, by Technology
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Component
      • 8.2.6.3.2. Market size and forecast, by Technology
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Component
    • 8.3.3. Market size and forecast, by Technology
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Component
      • 8.3.6.1.2. Market size and forecast, by Technology
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Component
      • 8.3.6.2.2. Market size and forecast, by Technology
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Component
      • 8.3.6.3.2. Market size and forecast, by Technology
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Component
      • 8.3.6.4.2. Market size and forecast, by Technology
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Component
      • 8.3.6.5.2. Market size and forecast, by Technology
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Component
      • 8.3.6.6.2. Market size and forecast, by Technology
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Component
    • 8.4.3. Market size and forecast, by Technology
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Component
      • 8.4.6.1.2. Market size and forecast, by Technology
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Component
      • 8.4.6.2.2. Market size and forecast, by Technology
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. Australia
      • 8.4.6.3.1. Market size and forecast, by Component
      • 8.4.6.3.2. Market size and forecast, by Technology
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. India
      • 8.4.6.4.1. Market size and forecast, by Component
      • 8.4.6.4.2. Market size and forecast, by Technology
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Component
      • 8.4.6.5.2. Market size and forecast, by Technology
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Component
      • 8.4.6.6.2. Market size and forecast, by Technology
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Component
    • 8.5.3. Market size and forecast, by Technology
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Component
      • 8.5.6.1.2. Market size and forecast, by Technology
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Component
      • 8.5.6.2.2. Market size and forecast, by Technology
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Market size and forecast, by Component
      • 8.5.6.3.2. Market size and forecast, by Technology
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Component
      • 8.5.6.4.2. Market size and forecast, by Technology
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Agilent Technologies, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. BioMerieux SA
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
    • 10.4.7. Key strategic moves and developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
    • 10.5.7. Key strategic moves and developments
  • 10.6. Miltenyi Biotec GmbH.
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
  • 10.7. Sartorius AG
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
  • 10.8. Sysmex Corporation
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
    • 10.8.7. Key strategic moves and developments
  • 10.9. Thermo Fisher Scientific Inc.
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. Cytek Biosciences
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 02. FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL INSTRUMENTS FLOW CYTOMETRY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL PLATFORM FLOW CYTOMETRY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL REPLACEABLE COMPONENT FLOW CYTOMETRY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 06. FLOW CYTOMETRY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL REAGENTS AND CONSUMABLES FLOW CYTOMETRY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 11. FLOW CYTOMETRY MARKET FOR CELL BASED FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. FLOW CYTOMETRY MARKET FOR BEAD BASED FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 14. FLOW CYTOMETRY MARKET FOR ACADEMIC AND CLINICAL APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL ACADEMIC AND CLINICAL APPLICATIONS FLOW CYTOMETRY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. FLOW CYTOMETRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC APPLICATIONS FLOW CYTOMETRY MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. FLOW CYTOMETRY MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. FLOW CYTOMETRY MARKET FOR MEDICAL SCHOOLS AND CLINICAL TESTING LABS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. FLOW CYTOMETRY MARKET FOR COMMERCIAL ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. FLOW CYTOMETRY MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. FLOW CYTOMETRY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. FLOW CYTOMETRY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. NORTH AMERICA FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. U.S. FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 31. U.S. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 32. U.S. FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. U.S. FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. CANADA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 35. CANADA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 36. CANADA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. CANADA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. MEXICO FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. FRANCE FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 52. FRANCE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. UK FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 56. UK FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 57. UK FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. UK FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. ITALY FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 60. ITALY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 61. ITALY FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. ITALY FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SPAIN FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 64. SPAIN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 65. SPAIN FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SPAIN FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 76. JAPAN FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 77. JAPAN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. CHINA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 81. CHINA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. CHINA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. CHINA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. AUSTRALIA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 85. AUSTRALIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 86. AUSTRALIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. AUSTRALIA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. INDIA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 89. INDIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 90. INDIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. INDIA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH KOREA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH KOREA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH KOREA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH KOREA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 97. REST OF ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 98. REST OF ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. REST OF ASIA-PACIFIC FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. LAMEA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 101. LAMEA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 102. LAMEA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. LAMEA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. LAMEA FLOW CYTOMETRY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 105. BRAZIL FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 106. BRAZIL FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 107. BRAZIL FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. BRAZIL FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. SAUDI ARABIA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 110. SAUDI ARABIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 111. SAUDI ARABIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. SAUDI ARABIA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. SOUTH AFRICA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 114. SOUTH AFRICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 115. SOUTH AFRICA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 116. SOUTH AFRICA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. REST OF LAMEA FLOW CYTOMETRY MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 118. REST OF LAMEA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 119. REST OF LAMEA FLOW CYTOMETRY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 120. REST OF LAMEA FLOW CYTOMETRY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 122. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 123. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 124. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 125. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
  • TABLE 126. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 127. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 128. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 129. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 130. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 131. BIOMERIEUX SA: KEY EXECUTIVES
  • TABLE 132. BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 133. BIOMERIEUX SA: PRODUCT SEGMENTS
  • TABLE 134. BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 135. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 136. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 137. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
  • TABLE 138. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 139. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
  • TABLE 140. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 141. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 142. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 143. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 144. DANAHER CORPORATION: KEY STRATERGIES
  • TABLE 145. MILTENYI BIOTEC GMBH.: KEY EXECUTIVES
  • TABLE 146. MILTENYI BIOTEC GMBH.: COMPANY SNAPSHOT
  • TABLE 147. MILTENYI BIOTEC GMBH.: PRODUCT SEGMENTS
  • TABLE 148. MILTENYI BIOTEC GMBH.: PRODUCT PORTFOLIO
  • TABLE 149. SARTORIUS AG: KEY EXECUTIVES
  • TABLE 150. SARTORIUS AG: COMPANY SNAPSHOT
  • TABLE 151. SARTORIUS AG: PRODUCT SEGMENTS
  • TABLE 152. SARTORIUS AG: PRODUCT PORTFOLIO
  • TABLE 153. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 154. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 155. SYSMEX CORPORATION: PRODUCT SEGMENTS
  • TABLE 156. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 157. SYSMEX CORPORATION: KEY STRATERGIES
  • TABLE 158. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 159. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 160. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 161. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 162. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 163. THERMO FISHER SCIENTIFIC INC. : KEY STRATERGIES
  • TABLE 164. CYTEK BIOSCIENCES: KEY EXECUTIVES
  • TABLE 165. CYTEK BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 166. CYTEK BIOSCIENCES: PRODUCT SEGMENTS
  • TABLE 167. CYTEK BIOSCIENCES: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. FLOW CYTOMETRY MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF FLOW CYTOMETRY MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN FLOW CYTOMETRY MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN FLOW CYTOMETRY MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL FLOW CYTOMETRY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. FLOW CYTOMETRY MARKET, BY COMPONENT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR CELL BASED FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR BEAD BASED FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR ACADEMIC AND CLINICAL APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. FLOW CYTOMETRY MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR MEDICAL SCHOOLS AND CLINICAL TESTING LABS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR COMMERCIAL ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF FLOW CYTOMETRY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. FLOW CYTOMETRY MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 29. U.S. FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. CANADA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. MEXICO FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. GERMANY FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. FRANCE FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. UK FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. ITALY FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SPAIN FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF EUROPE FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. JAPAN FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. CHINA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. INDIA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. SOUTH KOREA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. REST OF ASIA-PACIFIC FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. BRAZIL FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SAUDI ARABIA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. SOUTH AFRICA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. REST OF LAMEA FLOW CYTOMETRY MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 52. COMPETITIVE DASHBOARD
  • FIGURE 53. COMPETITIVE HEATMAP: FLOW CYTOMETRY MARKET
  • FIGURE 54. TOP PLAYER POSITIONING, 2022
  • FIGURE 55. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 56. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 57. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 58. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 59. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 60. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 62. BIOMERIEUX SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 64. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 65. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
  • FIGURE 66. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 69. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 72. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 73. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 74. SYSMEX CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 75. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 76. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 77. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 78. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)